Biotech

All Articles

Navigator increases $100M to build brand new autoimmune pipeline

.Sat nav Medicines has actually furnished itself with $100 million in series A funds as the youthful...

Duality seeks cash for ADC trials as IPO wave spreads to Asia

.China's Duality Biotherapeutics has submitted (PDF) paperwork for a Hong Kong IPO, finding an unrev...

YolTech sells China civil liberties to gene modifying treatment for $29M

.Four months after Mandarin genetics editing and enhancing business YolTech Therapeutics took its ch...

Addex stock rises after Indivior provides to $300M for substance

.Indivior is picking up a little particle allosteric modulator made to manage substance use problem ...

Molecular Allies adjusts AML test over 'suboptimal direct exposure'

.Molecular Companions has pinpointed "suboptimal visibility" to its tetra-specific T-cell engager as...

Despite blended market, a financial backing revival may be coming in Europe: PitchBook

.While the biotech assets scene in Europe has actually slowed rather complying with a COVID-19 backi...

8 months after a $213M fundraise, genetics publisher Tome helps make decreases

.After increasing $213 thousand in 2023-- one of the year's most extensive private biotech rounds-- ...

BioMarin develops exec group with biotech vets-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our summary of substantial leadership hirings, firings as...

Biopharma Q2 VC attacked highest degree given that '22, while M&ampA decreased

.Venture capital funding right into biopharma rose to $9.2 billion all over 215 sell the 2nd fourth ...

Bicara, Zenas seek IPOs to drive late-phase resources towards market

.Bicara Therapeutics as well as Zenas Biopharma have supplied fresh impetus to the IPO market along ...